Neumora Therapeutics Inc.... (NMRA)
1.90
-0.10 (-5.00%)
At close: Jan 28, 2025, 1:53 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Revenue | n/a | n/a | n/a | n/a |
| Cost of Revenue | 668.00K | 2.70M | 1.55M | n/a |
| Gross Profit | -668.00K | -2.70M | -1.55M | n/a |
| Operating Income | -188.19M | -135.87M | -237.32M | -95.52M |
| Interest Income | 16.61M | 4.56M | n/a | n/a |
| Pretax Income | -235.66M | -130.90M | -237.31M | -99.27M |
| Net Income | -235.93M | -130.90M | -237.31M | -99.27M |
| Selling & General & Admin | 44.81M | 31.12M | 24.55M | 8.39M |
| Research & Development | 142.72M | 104.75M | 212.78M | 87.13M |
| Other Expenses | n/a | 405.00K | 11.00K | -3.75M |
| Operating Expenses | 187.53M | 135.87M | 237.32M | 95.52M |
| Interest Expense | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | -668.00K | n/a | n/a | n/a |
| Cost & Expenses | 188.19M | 135.87M | 237.32M | 95.52M |
| Income Tax | 268.00K | -4.56M | 301.44K | -101.30K |
| Shares Outstanding (Basic) | 158.83M | 151.95M | 151.95M | 151.95M |
| Shares Outstanding (Diluted) | 158.83M | 151.95M | 151.95M | 151.95M |
| EPS (Basic) | -1.49 | -0.86 | -1.56 | -0.65 |
| EPS (Diluted) | -1.49 | -0.86 | -1.56 | -0.65 |
| EBITDA | -187.53M | -135.28M | -236.78M | -95.41M |
| Depreciation & Amortization | 668.00K | 2.70M | 1.55M | 105.00K |